Atlas Trials

A Study of Secutrelvir in Participants With Coronavirus Disease 2019 (COVID-19) Who Are at High Risk for Progression to Severe Disease

Clinical trial NCT07743580 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07743580
Sponsor
Shionogi
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
SARS-CoV-2
Start date
2026-08-06
Primary completion
2028-06-30
Enrollment
2000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.